|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | |
| A61K 38/23 | |||
| A61K 38/29 | |||
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/50 |
| (11) | Number of the document | 2152195 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08767936.1 |
| Date of filing the European patent application | 2008-05-29 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/006804 |
| Date | 2008-05-29 |
| (87) | Number | WO 2008/150426 |
| Date | 2008-12-11 |
| (30) | Number | Date | Country code |
| 940598 P | 2007-05-29 | US | |
| 128210 | 2008-05-28 | US |
| (72) |
STERN, William, US
CONSALVO, Angelo, P., US
|
| (73) |
Enteris BioPharma, Inc.,
83 Fulton Street, Boonton, NJ 07005,
US
|
| (54) | PEPTIDE PHARMACEUTICAL FOR ORAL DELIVERY |
| PEPTIDE PHARMACEUTICAL FOR ORAL DELIVERY |